By Rhys Dipshan | January 16, 2024
While experts see a difference in the performance of some generative AI models over others with certain legal tasks, the "right" model for a legal team will come down to a variety of factors.
By Cassandre Coyer | Rhys Dipshan | January 16, 2024
Navigating the Gen AI landscape can be challenging. But understanding the differences and similarities of the most common, and foundational, Gen AI models on the market can go a long way.
By Rhys Dipshan | January 16, 2024
Legaltech News caught up with Niloy Ray, shareholder and e-discovery counsel at Littler Mendelson, to discuss how the legal market can align its use of generative AI with its ethical obligations.
Legaltech News | Expert Opinion
By Stephanie Wilkins | January 16, 2024
Legal industry experts make their predictions for what we can expect to see in e-discovery in 2024.
Legaltech News | Expert Opinion
By Stephanie Wilkins | January 16, 2024
Legal industry experts make their predictions for what we can expect for data governance, knowledge management and AI usage in 2024.
By Mark Liang. Paige Hardy and Grace McFee | January 16, 2024
Part One of a Two-Part Article Under the current Alice framework, those attempting to patent AI innovations face an uphill battle. But, as the caselaw demonstrates, inventors and patent drafters can take steps to reduce the risk of AI patent claims being invalidated as abstract ideas.
By Amy Guthrie | January 16, 2024
Dozens of programs have been rolled out across Brazil's courts as innovators attempt to advance justice in one of the world's most-clogged legal systems.
By Amy Guthrie | January 16, 2024
Dozens of programs have been rolled out across Brazil's courts as innovators attempt to advance justice in one of the world's most-clogged legal systems.
By Cassandre Coyer | January 16, 2024
The two new capabilities, AI-Assisted Redlining and AI-Suggested Subtasks, will be available in Q1, with "many" other generative AI-powered features slated to come out throughout the year.
Connecticut Law Tribune | News
By Emily Cousins | January 12, 2024
The principal investigator allegedly did not follow U.S. Food and Drug Administration rules and regulations due to "mounting pressure to fast track [the drug] to market under exigent circumstances to meet artificial milestones set by BioXcel's biggest lenders Oaktree Capital Management, L.P. and Qatar Investment Authority," the complaint said.
Presented by BigVoodoo
Consulting Magazine identifies the best firms to work for in the consulting profession.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
The Los Angeles office of Epstein Becker & Green is seeking a partner-level attorney to work in its growing national management-side Emp...
Note: This position is hybrid, however, it is discretionary, and the office location is in Bradenton, Florida.Note: The salary range reflect...
Litigation defense commercial casualty/complex catastrophic cases. Flexible schedule with work in Philadelphia, Conshohocken, and/or remot...